News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AusBiotech Ltd. Investment Summit Heading for Melbourne


6/3/2013 9:26:32 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

28 May 2013 -- Australia Biotech Invest 2013, the largest life science investment meeting in Australia, will this year be held on 28 and 29 October 2013 at the Melbourne Convention and Exhibition Centre.

Coordinated by AusBiotech, the investment summit will offer a platform for Australian life science companies to showcase their company’s for investment and partnership opportunities.

Focussed networking events with short presentations, one-on-one meetings and associated networking activities will allow investors to gain the information they need to make informed decisions.

In addition, expert keynote presenters and investor panels will speak on the state of the global biotech investment environment and future growth markets.

The event will attract local and international decision makers from the investment community including venture capitalists, private equity firms and investment bankers, as well as from governments.

Traditionally, the investment summit has been held at the same location as AusBiotech’s National Biotechnology Conference, however this year the summit will be held in conjunction with Beacon’s Money and Mines event in Melbourne.

Beacon and AusBiotech have also partnered to deliver biotechnology investor meetings in Hong Kong.

Acting Chief Executive Officer of AusBiotech, Mr Glenn Cross, said having a standalone investment summit and partnering with Beacon will create a week-long investment mega-event.

“Australia Biotech Invest 2013 will lift the profile of the Australian biotechnology industry and create access to greater funding sources,” he said.

Independent research by Insync Surveys has shown the value of deals that were done as a result of the 2009 to 2010 events was at a minimum of $33 million, and this is expected to dramatically rise.

“The significant value generated clearly demonstrates the positive contribution that the investment summits have on the Australian biotech industry,” said Mr Cross.

Further information: Hayley Laing, Investment Program Manager, AusBiotech,

E: hlaing@ausbiotech.org

P: +61 (0) 3 9828 1435,

M: +61 (0) 0414 474 972

Media enquiries: Lorraine Chiroiu, AusBiotech’s Communications Manager,

E: lchiroiu@ausbiotech.org

P: +61 (0) 3 9828 1414,

M: +61 (0) 429 801 118



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES